-
Utilization and Costs of Laboratory Monitoring in Biological and Non-Biological Psoriasis Treatment – Large-Scale Claims Data Analysis
05 Aug 2025 00:05 GMT
… Codes of Lab Monitoring in Systemic Drug Treatment
Cost … .
Most systemic drugs require specific laboratory testing for blood … , Incyte, Janssen-Cilag, LEO Pharma, Medac, Novartis, Pierre Fabre … , Pfizer, Regeneron, Sanofi, Stiefel GSK, Tigercut and UCB. …
-
Psoriasis Pipeline Drugs Analysis 2025: Clinical Trials, EMA, PDMA, FDA Approvals, Therapies, Medication, NDA Approval, IND, Mechanism Of Action, Route Of Administration By Delveinsight
07 Jun 2025 02:16 GMT
… China.
In May 2024, Zai Lab administered the first dose to … – Psoriasis Treatment Market
Emerging Psoriasis Drugs Under Different Phases of Clinical … Biotech Inc.), Leo Pharma AS, Merck and Co. Inc., Novartis AG, Pfizer Inc., Stiefel Laboratories …
-
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors
02 Apr 2025 20:05 GMT
… Chief Executive Officer of Verrica Pharmaceuticals. “Gavin is a … of R&D at Stiefel Laboratories. He received his M …
YCANTH® is a proprietary drug-device combination product that … additional information. About Verrica Pharmaceuticals Inc.
Verrica is a …
-
Endor Labs: AI transparency vs ‘open-washing’
24 Feb 2025 23:44 GMT
… firm Endor Labs weighed in on these pressing topics.
Andrew Stiefel, Senior … Product Marketing Manager at Endor Labs, emphasised the … , operational risks, and openness.”
As Stiefel succinctly summarised: “Think about security …
-
Overview of CSU Symptoms
25 Jul 2025 12:39 GMT
Video content above is prompted by the following:
Chronic spontaneous urticaria (CSU) is a recurrent and unpredictable inflammatory skin condition characterized by itchy wheals and angioedema, affecting approximately 63% of patients with moderate to severe …
-
Todd Stiefel, Party of One
19 Feb 2025 20:59 GMT
… for Prosparody.
His family owned Stiefel Laboratories, the world’s largest private … to sell the company to pharma and biotech giant GSK in 2009 … Stiefel Laboratories employees as well as major nonprofits.
In 2020, Stiefel Laboratories and Charles Stiefel …
-
ANDA Approvals - New Drug Applications and 505(b)(2) Applications: Third Quarter
15 Nov 2024 22:16 GMT
Approval Date
Reference Listed Drug
Generic Drug Name
NDA Holder
ANDA Applicant
… ;05/2024
Soriatane
Acitretin
Stiefel Labs
Alembic
217774
08/05 …
Solu-Cortef
Hydrocortisone Sodium Succinate
Pharmacia and Upjohn
Cipla
214050
09 …
-
Rocket Lab USA, Inc. (NASDAQ:RKLB) Q3 2024 Earnings Call Transcript
13 Nov 2024 14:01 GMT
… Welcome everyone to the Rocket Lab Third Quarter 2024 Fiscal … Senior Communications Manager at Rocket Lab. You may begin.
Murielle … manufacturing and scaling to Rocket Lab. And Ken Possenriede also … line of Erik Rasmussen with Stiefel. Your line is open.
…
-
Acne Vulgaris Market Size to Reach USD 10.4 Billion by 2035 - Epidemiology Report by IMARC Group
15 Jul 2025 09:58 GMT
… marketed drugs and late-stage pipeline drugs.
In-Market Drugs
Drug …
Late-Stage Pipeline Drugs
Drug Overview
Mechanism of … Mayne Pharma
Almirall S.A./Paratek Pharmaceuticals
Stiefel Laboratories
Cosmo Pharmaceuticals
Biofrontera …
-
Alembic Pharmaceuticals receives final US FDA approval for Acitretin Capsules USP, 10 mg, 17.5 mg, 25 mg
08 Aug 2024 07:28 GMT
Mumbai: Alembic Pharmaceuticals Limited announced that … for its abbreviated new drug application (ANDA) Acitretin Capsules … to the reference listed drug product (RLD), Soriatane Capsules … , and 25 mg, of Stiefel Laboratories, Inc. Acitretin capsules are …
About
© 1995-2025